However, the WHO said vaccines should not have age restrictions. Indeed, there is “no reason to believe that there are different security profiles” in the older generation.

World Health Organization approves Sinovac on Tuesday COVID-19 (novel coronavirus infection) Emergency Vaccine – Second Chinese Jab Approved by WHO.

The United Nations Health Organization has approved CoronaVac, a double-dose vaccine from the Beijing-based company Sinovac. This vaccine has already been deployed in several countries around the world.

WHO Executive Director Tedros Adhanom Ghebreyesus told a press conference: “After confirming that the Sinovac-CoronaVac vaccine is safe, effective and of guaranteed quality, it will be on the list of uses of WHO emergency. I am happy to announce that I am registered.

“The CoronaVac is easy to store and is ideal for low-resource environments,” he added.

“It is important to quickly reach those who need these vital tools.

WHO said the Emergency Use Authorization (EUL) provides countries, donors, purchasing agencies and communities with assurance that vaccines meet international standards.

Last month, Sinopharm became the first Chinese vaccine approved by the WHO.

The organization also grants EUL status to vaccines manufactured by Pfizer / BioN Tech, Moderna, Johnson & Johnson and AstraZeneca Jab made in India, South Korea and the EU.

The WHO list paves the way for countries around the world, especially those without their own international standards regulators, to quickly approve and import vaccines for distribution.

It also opens the door for jabs entering the Covax Global Vaccine Sharing Facility, which aims to provide equitable access to dosages around the world, especially in poorer countries.

Currently only AstraZeneca and some Pfizer jabs run this program.

“The world is hopelessly multiple COVID-19 (novel coronavirus infection) Vaccines respond to the great inequality of access in the world, ”said Mariangela Simao, WHO deputy director for access to health products.

“We want manufacturers to join the Covax facility, share their know-how and data, and help control pandemics.”

Effective rate

“The WHO recommends that adults over 18 be vaccinated twice every two to four weeks,” the agency said in a statement.

“The vaccine efficacy results show that the vaccine prevented symptomatic disease and worsening in 51% of those vaccinated. COVID-19 (novel coronavirus infection) 100% of those questioned are hospitalized. “

Sinovac vaccine contains an inactivated form. Coronavirus It cannot cause disease. It also contains substances that help strengthen the immune response to the vaccine.

When attacked, the immune system identifies the inactivated virus as a foreign substance, makes antibodies against it, recognizes the activated virus, and protects the body.

Few people over the age of 60 have participated in clinical trials for Sinovac’s jab.

However, the WHO said vaccines should not have age restrictions. Indeed, there is “no reason to believe that there are different security profiles” in the older generation.

Sinovac jabs are already in use in 22 regions of the world. AFP to count.

In addition to China, countries using Sinovac are Chile, Brazil, Indonesia, Mexico, Thailand, and Turkey.

Chen Xu, Chinese Ambassador to Geneva, said CoronaVac’s EUL status has expanded the number of global pandemic tools.

“China will continue to work with the international community to promote accessibility and affordability for people. COVID-19 (novel coronavirus infection) The vaccines are particularly popular in developing countries. “

WHO approves Chinese Sinovac COVID-19 jab for emergency use, recommends use for adults-Health News, Firstpost Source link WHO approves Chinese Sinovac COVID-19 jab for emergency use, recommends use for adults-Health News, Firstpost



Source link

About The Author

Related Posts

Leave a Reply

Your email address will not be published.